LONDON--(BUSINESS WIRE)--Technavio has been monitoring the needle-free drug delivery devices market and it is poised to grow by USD 10.23 billion during 2020-2024, progressing at a CAGR of over 4% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request the Latest Free Sample Report on COVID-19 Impact
Frequently Asked Questions-
-
What is the year-over-year growth of the needle-free drug delivery devices market in 2020?
As per Technavio, the year-over-year growth of the market is 3.79% in 2020. -
At what rate is the market projected to grow during the forecast period 2020-2024?
Growing at a CAGR of over 4%, the market growth will accelerate in the forecast period. -
What is the key factor driving the market?
Technological advances in needle-free drug delivery devices. -
Who are the top players in the market?
3M Co., Antares Pharma Inc., Becton, Dickinson and Co., Enesi Pharma Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Mylan NV, Novartis AG, PharmaJet Inc., and Valeritas Holdings Inc. are the top players in the market. -
Which region is expected to hold the highest market share in the market?
North America. -
What is the major trend for needle-free drug delivery devices market?
Increasing government initiatives. -
Based on segmentation by product, which product segment is expected to witness the fastest growth in the global market?
Inhalers.
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. 3M Co., Antares Pharma Inc., Becton, Dickinson and Co., Enesi Pharma Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Mylan NV, Novartis AG, PharmaJet Inc., and Valeritas Holdings Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Technological advances in needle-free drug delivery devices have been instrumental in driving the growth of the market. However, the high costs associated with needle-free drug delivery devices might hamper market growth.
Needle-free Drug Delivery Devices Market 2020-2024: Segmentation
Needle-free Drug Delivery Devices Market is segmented as below:
-
Product
- Inhalers
- Transdermal Patches
- Jet Injectors
-
Geographic Landscape
- Asia
- Europe
- North America
- ROW
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40749
Needle-free Drug Delivery Devices Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our needle-free drug delivery devices market report covers the following areas:
- Needle-free Drug Delivery Devices Market size
- Needle-free Drug Delivery Devices Market trends
- Needle-free Drug Delivery Devices Market industry analysis
This study identifies the increasing prevalence of chronic diseases as one of the prime reasons driving the needle-free drug delivery devices market growth during the next few years.
Needle-free Drug Delivery Devices Market 2020-2024: Vendor Analysis
We provide a detailed analysis of around 25 vendors operating in the needle-free drug delivery devices market, including some of the vendors such as 3M Co., Antares Pharma Inc., Becton, Dickinson and Co., Enesi Pharma Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Mylan NV, Novartis AG, PharmaJet Inc., and Valeritas Holdings Inc. Backed with competitive intelligence and benchmarking, our research reports on the needle-free drug delivery devices market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform
Needle-free Drug Delivery Devices Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist needle-free drug delivery devices market growth during the next five years
- Estimation of the needle-free drug delivery devices market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the needle-free drug delivery devices market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of needle-free drug delivery devices market vendors
Table of Contents:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Value chain analysis
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2019
- Market size and forecast 2019-2024
- Market outlook
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Inhalers - Market size and forecast 2019-2024
- Transdermal patches - Market size and forecast 2019-2024
- Jet injectors - Market size and forecast 2019-2024
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Technological advances in needle-free drug delivery devices
- Research and funding for development of needle-free drug delivery devices
- Increasing government initiatives
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- 3M Co.
- Antares Pharma, Inc.
- Becton, Dickinson and Co.
- Enesi Pharma Ltd.
- GlaxoSmithKline Plc
- Inovio Pharmaceuticals Inc.
- Mylan NV
- Novartis AG
- PharmaJet Inc.
- Valeritas Holdings Inc.
PART 14: APPENDIX
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
